Eureka 93 Inc., a cannabidiol (CBD) life sciences company, engages in the research, development, extraction, production, processing, and distribution of CBD and other cannabinoids in the United States and Canada. The company offers hemp-derived CBD products, full plant extracts, and isolate powder. It is also involved in the development and manufacture of natural health products, as well as nutrac...
Eureka 93 reported revenue of 751,000 CAD for fiscal year 2018, and net income of -18.98 million CAD. In Q1 2019 (the quarter ended March 31, 2019) revenue was 1.16 million CAD.
Figures from company filings; latest fiscal year ended December 31, 2018.
No profile data available.